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Conclusion: A learning system based on SVM trained with mp-
MR data has been presented. Reported results show that this 
learning scheme can provide a probability map of the area of 
relapse of GBM in a stable and accurate manner. This study 
suggests the potential of mp-MR data in addressing specific 
questions in GBM imaging. 
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Purpose or Objective: Diffusion tensor magnetic resonance 
imaging (DTI) is a non-invasive modality for determination of 
water diffusion properties. Fractional anisotropy (FA) 
quantifies the extent of directionality of water diffusion. We 
investigated absorbed dose as a predictor of FA change in the 
corpus callosum (CC) following radiation therapy for high-
grade glioma. 
 
Material and Methods: Fifteen patients with high-grade 
glioma underwent DTI scans before, and ten months after 
radiation therapy to 59.4-60 Gy. Diffusion data were acquired 
on a 3T MRI scanner. Using an automated white matter fiber 
tracking technique, 23 fiber tracts were segmented on the 
baseline and follow-up DTI images. The CT images used for 
treatment planning and both DTI image sets were aligned 
using non-linear registration. This way, the baseline FA, the 
follow-up FA, and the absorbed dose could be determined for 
each voxel in all 15 patients. For each voxel in the CC, we 
calculated the FA change as FAfollow-up /FAbaseline and 
dichotomized the data into a binary outcome variable using 
0.5 as cutoff. For all 15 patients, logistic regression was used 
to determine dose-response curve parameters (D50 and g50) 
and their confidence intervals (CIs). We used the area under 
the receiver-operating characteristics curve (AUC) to 
evaluate the discriminative ability of the voxel dose. Then, 
we estimated dose-response curve parameters and calculated 
the AUC for each patient individually. 
 
Results: The median age was 59 (range: 40-85) years. The 
average CC volume and average CC mean absorbed dose was 
62±8 cm3 and 26±14 Gy (1 SD), respectively. Using data from 
99 691 voxels, the estimated parameters for the dose-
response curve for all patients (upper panel in Figure 1) were 
D50=88.0±0.1 Gy and γ50=0.80±0.01 (95% CIs). The AUC was 
0.71 indicating good discriminative ability. For nine out of 15 
patients, the individual AUC was ≥0.60, indicating that higher 
absorbed dose is associated with higher probability of FA 
change ≥0.5. Dose -response curves for those patients are 
shown in the lower panel in Figure 1 and their estimated 
parameter values in Table 1. Individual D50s varied between 
41.3 and 125.9 Gy. 
 
 
 
 
Conclusion: Absorbed dose was a significant predictor of FA 
change in the CC. This was the case both when all patients 
were pooled for analysis, and in nine out of 15 patients when 
analyzed separately. More detailed analyses are needed to 
better understand the effect radiation has on water diffusion 
in brain white matter. 
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Purpose or Objective: Radiation induced xerostomia is 
related to the dose given to the parotid glands (PG). 
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Nevertheless, substantial unexplained variability remains in 
the development of late xerostomia. To understand this 
variation becomes increasingly important with the advent of 
more conformal radiation techniques. Our hypothesis is that 
the patient-specific late response to radiotherapy (RT) is 
associated with changes in CT images and xerostomia scores 
early after RT. 
 
Material and Methods: Parotid gland (PG) image 
characteristics were extracted from CTs before (T0) and 
after RT (6 weeks post RT) of 110 HNC patients. The 
differences between those two time points resulted in 
potential Δ CT Image Biomarkers (IBMs). These potential Δ CT 
IBMs represent geometric (20) and CT intensity (24) changes 
of the PG. Furthermore, the scored xerostomia of the 
patients before (XERbaseline) and 6 weeks post RT 
(XER6w_post), tumour, patient and dose characteristics were 
included. To identify variables that were associated with the 
endpoint moderate-to-severe xerostomia 12 months after RT 
(XER12m) whilst reducing multicollinearity, variables were 
first omitted based on inter-variables correlation. Second, 
multivariable selection was conducted by bootstrapped 
forward selection based on log-likelihood performance. The 
performance of the resulting logistic regression models was 
evaluated with the area under the ROC-curve (AUC) and 
Nagelkerke R2 index. All models were internally cross 
validated. 
 
Results: Multivariable analysis was performed with 23 Δ CT 
IBMs. The primarily selected IBM was ∆ volume (between T0 
and 6 weeks post RT) of the PG (figure) (p<0.001). Larger 
volume change was related to a higher chance of XER12m. 
Furthermore, the XER6w_post and XERbaseline were very 
prognostic. The performance of the multivariable model was 
high with an AUC of 0.89 and R2 of 0.54 (table). This model 
showed to be stable when it was internally validated (AUC-
cross=0.88, R2-cross=0.53). Moreover, dose parameters did 
not add to the performance of the model (AUC-cross=0.88, 
R2-cross=0.52). ∆ Volume made dose parameters redundant, 
suggesting that PG volume changes are related to the 
patient-specific response to dose. 
 
 
Conclusion: Change of PG volume 6 weeks post RT showed to 
be strongly related to late xerostomia. Moreover, together 
with xerostomia scores before and 6 weeks after RT, 
outstanding performance was obtained to predict XER12m. 
We believe that this model can contribute to the 
understanding of the patient-specific response to RT in 
developing late xerostomia. Secondly, it can serve as a 
quantitative measure for late damage to the PG early after 
treatment. The next step will be to investigate whether ∆ PG 
Volume and xerostomia determined early in treatment can be 
used to predict late xerostomia, to select patients with a 
large risk on late xerostomia for proton treatment. 
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Purpose or Objective: Pulmonary complications remain a 
major dose limiting factor for lung cancer radiotherapy. 
Pulmonary function loss is known to correlate with physical 
lung dose, but better prediction accuracy is desired. This 
work investigates the potential of 4D CT-based functional 
imaging to improve the prediction of radiation-induced 
pulmonary function loss. 
 
Material and Methods: 80 lung cancer patients each received 
a treatment planning 4D CT scan prior to radiotherapy. To 
quantify pulmonary functional loss the patients also 
underwent spirometry measurements of forced expiratory 
volume (FEV1) and forced vital capacity (FVC) immediately 
before radiotherapy and at 3, 6, and 9 months follow-up. For 
each patient, the pre-treatment regional ventilation was 
evaluated by performing deformable image registration (DIR) 
between the CT inhale and exhale phase images. The 
Jacobian determinant (J-1) of the DIR motion field was used 
as a ventilation surrogate. The functional mean lung dose 
(fMLD) was then defined as the regional lung dose weighted 
spatially by the regional ventilation. The physical mean lung 
dose (MLD) was calculated without ventilation 
weighting.Logistic regression was used to compare the ability 
of fMLD and MLD to predict clinical pulmonary function loss, 
defined as a reduction of the FEV1 and FVC to less than 90% 
of their initial values at 6-months post treatment. To 
minimise noise in the spirometry data, the FEV1 and FVC 
values at 6 months were estimated based on a fit to the 
available data up to 9 months post-treatment. 
 
Results: Both functional and physical lung dose correlated 
with the onset of clinical pulmonary function loss. The figure 
and table show the logistic regression results and model 
parameters respectively. We observed a 0.7 Gy decrease in 
the tolerance dose (D50) when using fMLD as opposed to MLD. 
However, the difference in log-likelihood between the MLD 
and fMLD based models was not statistically significant 
different from zero. Thus we did not observe a significant 
